Drug Detail

Information about GDC-0941 + GDC-0973

Generic Name
IND	GDC-0941 + GDC-0973
Brand Name (US)
Manufacturer	Genentech
Drug Type	Kinase inhibitor
Delivery	Oral
Approval Status	Phase 1
Indications
Overall Strategy	Oncogenic Signal Path Based
Strategy	Block related tumor signal paths
Drug Category	MEK inhibitor + PI3K inhibitor

Links
Trials of this drug
	A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0973 in Combination With GDC-0941 When Administered Daily in Patients With Locally Advanced or Metastatic Solid Tumors

Trial results